In cases where nutritional interventions are insufficient, pharmacotherapy with agents such as acarbose, somatostatin analogues (octreotide and pasireotide), GLP-1 receptor agonists (liraglutide), calcium channel blockers (verapamil), and emerging therapies, including herbal medicine, may be considered
Retatrutide Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial
Growth hormone and its downstream messenger, IGF-1, support tissue repair and protein turnover, which speaks to loss of proteostasis, the slow breakdown of your cells quality control
The therapy helps patients feel an increase in energy the same day, while other benefits appear with repeated sessions
How long after stopping GLP-1 medication can I safely try to conceive